miR-30b-5p and miR-30c-5p have been observed to target the eIF2α protein, promoting cell survival in hepatocellular carcinoma (HCC) and breast cancer when treated with PS-341 [67]. This evidence concerns the gene EIF2A and hepatocellular carcinoma.